[
  {
    "date": "2023-12-30",
    "symbol": "ATXI",
    "period": "FY",
    "entitycentralindexkey": 1644963,
    "entityregistrantname": "AVENUE THERAPEUTICS, INC.",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38114",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "47-4113275",
    "entityaddressaddressline1": "1111 Kane Concourse, Suite 301",
    "entityaddresscityortown": "Bay Harbor Islands",
    "entityaddressstateorprovince": "FL",
    "entityaddresspostalzipcode": 33154,
    "cityareacode": 781,
    "localphonenumber": "652-4500",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "ATXI",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "auditorname": "KPMG LLP",
    "auditorlocation": "New York, NY",
    "auditorfirmid": 185,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 2000000,
    "preferredstocksharesissued": 250000,
    "preferredstocksharesoutstanding": 250000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 75000000,
    "commonstocksharesissued": 25597622,
    "commonstocksharesoutstanding": 25597622,
    "paymentsforstockpurchasecosts": 500000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.49,
    "classofwarrantorrightissuedduringperiod": 49479398,
    "stockissuedduringperiodsharesnewissues": 374644,
    "saleofstocknumberofsharesissuedintransaction": 767085,
    "retainedearningsaccumulateddeficit": -90928000,
    "numberofreportablesegments": 1,
    "numberofoperatingsegments": 1,
    "researchanddevelopmentexpenselicensesacquired": 300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "stockissuedduringperiodshareslicenseexpense": 1108270,
    "stockissuedduringperiodvaluelicenseexpense": 1230000,
    "proceedsfromequityfee": 23000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 3352489,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y7M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 3333,
    "allocatedsharebasedcompensationexpense": 199000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 900000,
    "deferredtaxassetsvaluationallowance": 35672000,
    "operatinglosscarryforwards": 83900000,
    "taxcreditcarryforwardamount": 2900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 98137,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 12.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 85000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1685000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 1.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1685000000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 262500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 1.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P9Y6M",
    "classofwarrantorrightoutstanding": 39344932,
    "classofwarrantorrightaggregateintrinsicvalue": 1000,
    "classofwarrantorrightgrantedduringperiodexercisepriceofwarrantsorrights": 0.26,
    "classofwarrantorrightexercisedduringperiod": 14272382,
    "profitloss": -10488000,
    "sharebasedcompensation": 906000,
    "fairvalueadjustmentofwarrants": -4258000,
    "issuanceofstockunderfoundersagreement": 371000,
    "commonstockissuedtofortressvalue": 72000,
    "issuanceofstockforlicensesacquired": 1230000,
    "researchanddevelopmentlicenseacquriedexpense": 3000000,
    "licenseexpensespaidinkind": 6000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -70000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -662000,
    "netcashprovidedbyusedinoperatingactivities": -9451000,
    "paymentstoacquireresearchanddevelopmentlicenses": 3000000,
    "netcashprovidedbyusedininvestingactivities": -3000000,
    "issuanceofcommonstockprefundwarrantsandwarrants": 7525000,
    "proceedsfromwarrantexercises": 1000,
    "netcashprovidedbyusedinfinancingactivities": 7526000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -4925000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 1783000,
    "deferredtaxassetsoperatinglosscarryforwards": 27318000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 287000,
    "deferredtaxassetsinprocessresearchanddevelopment": 2884000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 4000,
    "deferredtaxassetssection174capitalization": 2253000,
    "deferredtaxassetstaxcreditcarryforwards": 2926000,
    "deferredtaxassetsgross": 35672000,
    "sharesoutstanding": 250000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 654000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 906000,
    "commonsharesissuablefoundersagreement": 371000,
    "sharesandwarrantsissuedduringperiodvalue": 1000,
    "adjustmenttoadditionalpaidincapitalissuanceofsubsidiariescommonsharesforlicenseexpenses": 6000,
    "stockissuedduringperiodsharesexerciseofwarrants": 14272382,
    "stockissuedduringperiodvalueexercise0fwarrants": 1000,
    "netincomelossattributabletononcontrollinginterest": -111000,
    "netincomelossavailabletocommonstockholdersbasic": -10377000,
    "stockissuedduringperiodvaluenewissues": 72000,
    "stockandprefundedwarrantsissuedduringperiodsharesnovember2023publicofferingnetofissuancecosts": 3853400,
    "stockandprefundedwarrantsissuedduringperiodvaluesnovember2023publicofferingnetofissuancecosts": 1000,
    "stockandprefundedwarrantsissuedduringperiodsharesprivateplacementnetofissuancecosts": 448000,
    "adjustmentstoadditionalpaidincapitalprivateplacementoffering": 550000,
    "noncontrollinginterestdecreasefromdeconsolidation": 178000,
    "accountspayablecurrent": 78000,
    "accruedemployeebenefitscurrent": 11000,
    "otheraccruedliabilitiescurrent": 198000,
    "accountspayableandaccruedliabilitiescurrent": 287000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0414,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.2572,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 426000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityissues": 2235000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": 2183000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.11,
    "effectiveincometaxratereconciliationchangeinenactedstatetaxratepercent": 0.01,
    "effectiveincometaxratereconciliationtaxcarryforwardcreditpercent": 0.01,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.01,
    "effectiveincometaxratereconciliationchangeinfairmarketvalueofwarrant": 0.12,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.45,
    "researchanddevelopmentexpense": 6131000,
    "researchanddevelopmentexpenseforlicensesacquired": 4230000,
    "generalandadministrativeexpense": 4179000,
    "operatingincomeloss": -14540000,
    "investmentincomeinterest": 126000,
    "financingcostswarrantliabilities": 332000,
    "earningspersharebasic": -0.98,
    "weightedaveragenumberofsharesoutstandingbasic": 10591636,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 98137,
    "cashandcashequivalentsatcarryingvalue": 1783000,
    "prepaidexpenseandotherassetscurrent": 67000,
    "assets": 1850000,
    "derivativeliabilitiescurrent": 586000,
    "liabilitiescurrent": 1196000,
    "liabilities": 1196000,
    "commonstockvalue": 3000,
    "additionalpaidincapital": 92507000,
    "stockholdersequity": 1582000,
    "minorityinterest": -928000,
    "liabilitiesandstockholdersequity": 1850000,
    "warrantsandrightsoutstandingmeasurementinput": 0.16
  },
  {
    "date": "2022-12-30",
    "symbol": "ATXI",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2022-12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38114",
    "entityregistrantname": "AVENUE THERAPEUTICS, INC.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "47-4113275",
    "entityaddressaddressline1": "1111 Kane Concourse, Suite 301",
    "entityaddresscityortown": "Bay Harbor Islands",
    "entityaddressstateorprovince": "FL",
    "entityaddresspostalzipcode": 33154,
    "cityareacode": 781,
    "localphonenumber": "652-4500",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "ATXI",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1644963,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorname": "KPMG LLP",
    "auditorfirmid": 185,
    "auditorlocation": "New York, New York",
    "cashandcashequivalentsatcarryingvalue": 6708000,
    "duefromotherrelatedpartiescurrent": 90000,
    "prepaidexpenseandotherassetscurrent": 137000,
    "assets": 6845000,
    "accountspayableandaccruedliabilitiescurrent": 949000,
    "accountspayableandaccruedexpensesrelatedpartycurrent": 21000,
    "warrantsandrightsoutstanding": 2609000,
    "liabilitiescurrent": 3579000,
    "liabilities": 3579000,
    "additionalpaidincapitalcommonstock": 84456000,
    "retainedearningsaccumulateddeficit": -80551000,
    "stockholdersequity": 3905000,
    "minorityinterest": -639000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 3266000,
    "liabilitiesandstockholdersequity": 6845000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 2000000,
    "preferredstocksharesissued": 250000,
    "preferredstocksharesoutstanding": 250000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 20000000,
    "commonstocksharesissued": 4773841,
    "commonstocksharesoutstanding": 1405959,
    "researchanddevelopmentexpense": 2698000,
    "generalandadministrativeexpense": 5345000,
    "operatingincomeloss": -8043000,
    "investmentincomeinterest": 20000,
    "financingcostsderivativewarrantliabilities": 1160000,
    "fairvalueadjustmentofwarrants": -5580000,
    "profitloss": -3603000,
    "netincomelossattributabletononcontrollinginterest": -51000,
    "netincomeloss": -3552000,
    "earningspersharebasicattributabletocommonstockholders": -1.63,
    "earningspersharedilutedattributabletocommonstockholders": -1.63,
    "weightedaveragenumberofsharesoutstandingbasic": 2185159,
    "weightedaveragenumberofdilutedsharesoutstanding": 2185159,
    "sharesoutstanding": 250000,
    "stockissuedduringperiodvaluesharebasedcompensation": 649000,
    "stockissuedduringperiodsharessharebasedcompensation": 75505,
    "commonsharesissuablefoundersagreement": 526000,
    "sharesandwarrantsissuedduringperiodvalue": 3205000,
    "sharesandwarrantsissuedduringperiodshares": 3636365,
    "stockrepurchasedduringperiodvalue": 1104000,
    "stockrepurchasedduringperiodshares": -388888,
    "adjustmenttoadditionalpaidincapitalassetacquisitions": 99000,
    "adjustmenttoadditionalpaidincapitalissuanceofsubsidiariescommonsharesforlicenseexpenses": 4000,
    "shareissuedduringperiodvalueonexerciseofwarrants": 237000,
    "shareissuedduringperiodsharesonexerciseofwarrants": 44900,
    "noncontrollinginterestincreasefromsaleofparentequityinterest": 588000,
    "netincomelossavailabletocommonstockholdersbasic": -3552000,
    "sharebasedcompensation": 649000,
    "adjustmentsforcommonsharesissuable": 526000,
    "licenseexpensespaidinkind": 4000,
    "increasedecreaseinduetootherrelatedpartiescurrent": 90000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 30000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 385000,
    "increasedecreaseinduetorelatedparties": -37000,
    "netcashprovidedbyusedinoperatingactivities": -7596000,
    "proceedsfromissuanceofprivateplacement": 12005000,
    "paymentsforrepurchaseofequity": 1104000,
    "proceedsfromwarrantexercises": 148000,
    "paymentsofstockissuancecosts": 508000,
    "netcashprovidedbyusedinfinancingactivities": 10541000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 2945000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 6708000,
    "fairvalueofassetsacquired": 99000,
    "unpaidofferingcosts": 14000,
    "warrantsandrightsoutstandingmeasurementinput": 1.16,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 13137,
    "shorttermdebtterms": "three months",
    "increasedecreaseinfairvalueofwarrantliability": 5600000,
    "researchanddevelopmentexpenselicensesacquired": 268000,
    "relatedpartytransactionreimbursableamount": 200000,
    "proceedsfromequityfee": 10500000,
    "accountspayablecurrent": 129000,
    "accruedemployeebenefitscurrent": 199000,
    "invagencontingentfee": 208000,
    "otheraccruedliabilitiescurrent": 413000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 13137,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 5166119,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 666,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 80615,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 12.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.6713,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 13.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 40.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedinperiod": -1029200,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageexerciseprice": 3.3016,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedweightedaverageexerciseprice": 0.1441,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 1000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 266666,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "10 years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 122489,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 3300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y11M15D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvesteduponperformance": 3333,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.1,
    "effectiveincometaxratereconciliationchangeinenactedstatetaxratepercent": -0.01,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.22,
    "effectiveincometaxratereconciliationotheradjustments": 0.03,
    "effectiveincometaxratereconciliationtaxcredits": 0.04,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.12,
    "effectiveincometaxratereconciliationsection162mdisallowancelimitoncompensation": -0.03,
    "effectiveincometaxratereconciliationchangeinfairmarketvalueofwarrant": 0.48,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.49,
    "deferredtaxassetsoperatinglosscarryforwards": 25660000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 42000,
    "deferredtaxassetsinprocessresearchanddevelopment": 1603000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 64000,
    "deferredtaxassetsbusinessinterestexpensedisallowance": 122000,
    "deferredtaxassetssection174capitalization": 622000,
    "deferredtaxassetstaxcreditcarryforwards": 2859000,
    "deferredtaxassetsgross": 30972000,
    "deferredtaxassetsvaluationallowance": 30972000,
    "operatinglosscarryforwards": 78300000,
    "operatinglosscarryforwardexpireperiod": 2034,
    "taxcreditcarryforwardamount": 2900000,
    "valuationallowancedeferredtaxassetchangeinamount": 31000000
  },
  {
    "date": "2021-12-30",
    "symbol": "ATXI",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2021-12-31",
    "entityregistrantname": "AVENUE THERAPEUTICS, INC.",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38114",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "47-4113275",
    "entityaddressaddressline1": "Delaware",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10036,
    "cityareacode": 781,
    "localphonenumber": "652-4500",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1644963,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "ATXI",
    "securityexchangename": "NASDAQ",
    "entityextransitionperiod": "true",
    "auditorname": "BDO USA, LLP",
    "auditorfirmid": 243,
    "auditorlocation": "New York, NY",
    "cashandcashequivalentsatcarryingvalue": 3763000,
    "duefromotherrelatedpartiescurrent": 90000,
    "prepaidexpenseandotherassetscurrent": 107000,
    "assetscurrent": 3960000,
    "assets": 3960000,
    "accountspayableandaccruedliabilitiescurrent": 451000,
    "accountspayableandaccruedexpensesrelatedpartycurrent": 58000,
    "liabilitiescurrent": 509000,
    "liabilities": 509000,
    "commonstockvalue": 2000,
    "additionalpaidincapitalcommonstock": 80448000,
    "retainedearningsaccumulateddeficit": -76999000,
    "stockholdersequity": 3451000,
    "liabilitiesandstockholdersequity": 3960000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 2000000,
    "preferredstocksharesissued": 250000,
    "preferredstocksharesoutstanding": 250000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 50000000,
    "commonstocksharesissued": 21089658,
    "commonstocksharesoutstanding": 21089658,
    "researchanddevelopmentexpense": 1254000,
    "generalandadministrativeexpense": 2484000,
    "operatingincomeloss": -3738000,
    "investmentincomeinterest": 7000,
    "netincomeloss": -3731000,
    "earningspersharebasic": -0.22,
    "earningspersharediluted": -0.22,
    "weightedaveragenumberofsharesoutstandingbasic": 16997564,
    "weightedaveragenumberofdilutedsharesoutstanding": 16997564,
    "sharesoutstanding": 250000,
    "stockissuedduringperiodvaluesharebasedcompensation": 442000,
    "stockissuedduringperiodsharessharebasedcompensation": 192060,
    "stockissuedduringperiodvalueother": 4381000,
    "stockissuedduringperiodsharesother": 4148905,
    "shareissuedduringperiodshareswarrantsexercised": 890,
    "profitloss": -3731000,
    "sharebasedcompensation": 442000,
    "increasedecreaseinduetootherrelatedpartiescurrent": -90000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -6000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -406000,
    "increasedecreaseinduetorelatedparties": 29000,
    "netcashprovidedbyusedinoperatingactivities": -3750000,
    "proceedsfromissuanceofcommonstock": 5044000,
    "paymentsofstockissuancecosts": 663000,
    "netcashprovidedbyusedinfinancingactivities": 4381000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 631000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 3763000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1416356,
    "relatedpartytransactionreimbursableamount": 200000,
    "accountspayablecurrent": 304000,
    "accruedemployeebenefitscurrent": 24000,
    "otheraccruedliabilitiescurrent": 123000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1416356,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 839686,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 437586,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 125654,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 3.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 7.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 4.97,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedinperiod": -890,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageexerciseprice": 0.6691,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedweightedaverageexerciseprice": 0.0001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 11000,
    "shareprice": 1.07,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P0Y9M3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvesteduponperformance": 50000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 4000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "10 years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1827336,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 600000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.13,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.11,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.23,
    "deferredtaxassetsoperatinglosscarryforwards": 23719000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 293000,
    "deferredtaxassetsgoodwillandintangibleassets": 1162000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 6000,
    "deferredtaxassetstaxcreditcarryforwards": 2640000,
    "deferredtaxassetsgross": 27820000,
    "deferredtaxassetsvaluationallowance": 27820000,
    "operatinglosscarryforwards": 71200000,
    "operatinglosscarryforwardexpireperiod": 2034,
    "taxcreditcarryforwardamount": 2600000,
    "valuationallowancedeferredtaxassetchangeinamount": 27800000
  },
  {
    "date": "2020-12-30",
    "symbol": "ATXI",
    "period": "FY",
    "documenttype": "10-K",
    "documentperiodenddate": "2020-12-31",
    "entityregistrantname": "AVENUE THERAPEUTICS, INC.",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1644963,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "ATXI",
    "securityexchangename": "NASDAQ",
    "entityextransitionperiod": "true",
    "cashandcashequivalentsatcarryingvalue": 3100000,
    "prepaidexpenseandotherassetscurrent": 113000,
    "assets": 3245000,
    "accountspayableandaccruedliabilitiescurrent": 857000,
    "accountspayableandaccruedexpensesrelatedpartycurrent": 29000,
    "liabilitiescurrent": 886000,
    "liabilities": 886000,
    "commonstockvalue": 2000,
    "additionalpaidincapitalcommonstock": 75625000,
    "retainedearningsaccumulateddeficit": -73268000,
    "stockholdersequity": -73268000,
    "liabilitiesandstockholdersequity": 3245000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 2000000,
    "preferredstocksharesissued": 250000,
    "preferredstocksharesoutstanding": 250000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 50000000,
    "commonstocksharesissued": 16747803,
    "commonstocksharesoutstanding": 16747803,
    "researchanddevelopmentexpense": 2866000,
    "generalandadministrativeexpense": 2347000,
    "operatingincomeloss": -5213000,
    "investmentincomeinterest": 62000,
    "netincomeloss": -5151000,
    "earningspersharebasicanddiluted": -0.31,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 16506447,
    "sharesoutstanding": 250000,
    "stockissuedduringperiodvaluesharebasedcompensation": 710000,
    "stockissuedduringperiodsharessharebasedcompensation": 65000,
    "shareissuedduringperiodshareswarrantsexercised": 613,
    "sharebasedcompensation": 700000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -57000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -244000,
    "increasedecreaseinduetorelatedparties": 15000,
    "netcashprovidedbyusedinoperatingactivities": -4613000,
    "milestonepaymentforresearchanddevelopmentlicenses": 1000000,
    "netcashprovidedbyusedininvestingactivities": -1000000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -5613000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 3132000,
    "milestonepaymentstriggeredamount": 5000000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1139910,
    "debtinstrumentinterestrateeffectivepercentage": 0.07,
    "accountspayablecurrent": 143000,
    "accruedemployeebenefitscurrent": 23000,
    "otheraccruedliabilitiescurrent": 691000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 15841,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 176413,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 81665,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 5.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 10.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 5.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedinperiod": -613,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageexerciseprice": 0.6315,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedweightedaverageexerciseprice": 0.0001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 84000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvesteduponperformance": 487586,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 2000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "10 years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 229436,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 500000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.13,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.06,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.4,
    "deferredtaxassetsoperatinglosscarryforwards": 22240000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 760000,
    "deferredtaxassetsgoodwillandintangibleassets": 1283000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 16000,
    "deferredtaxassetstaxcreditcarryforwards": 2640000,
    "deferredtaxassetsgross": 26939000,
    "deferredtaxassetsvaluationallowance": 26939000,
    "operatinglosscarryforwards": 14500000,
    "operatinglosscarryforwardexpireperiod": 2028,
    "taxcreditcarryforwardamount": 2600000
  },
  {
    "date": "2019-12-30",
    "symbol": "ATXI",
    "period": "FY",
    "documenttype": "10-K",
    "documentperiodenddate": "2019-12-31",
    "entityregistrantname": "AVENUE THERAPEUTICS, INC.",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1644963,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "tradingsymbol": "ATXI",
    "entityextransitionperiod": "true",
    "cashandcashequivalentsatcarryingvalue": 8745000,
    "prepaidexpenseandotherassetscurrent": 170000,
    "assets": 8915000,
    "accountspayableandaccruedliabilitiescurrent": 1101000,
    "accountspayableandaccruedexpensesrelatedpartycurrent": 14000,
    "licensespayablecurrent": 1000000,
    "liabilitiescurrent": 2115000,
    "liabilities": 2115000,
    "commonstockvalue": 2000,
    "additionalpaidincapitalcommonstock": 74915000,
    "retainedearningsaccumulateddeficit": -68117000,
    "stockholdersequity": -68117000,
    "liabilitiesandstockholdersequity": 8915000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 2000000,
    "preferredstocksharesissued": 250000,
    "preferredstocksharesoutstanding": 250000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 50000000,
    "commonstocksharesissued": 16682190,
    "commonstocksharesoutstanding": 16682190,
    "researchanddevelopmentexpense": 22194000,
    "researchanddevelopmentexpenselicensesacquired": 1000000,
    "generalandadministrativeexpense": 3071000,
    "operatingincomeloss": -26265000,
    "investmentincomeinterest": 357000,
    "netincomeloss": -25908000,
    "earningspersharebasicanddiluted": -1.65,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 15721619,
    "sharesoutstanding": 250000,
    "stockissuedduringperiodvaluesharebasedcompensation": 1839000,
    "stockissuedduringperiodsharessharebasedcompensation": 95000,
    "stockissuedduringperiodvalueother": 1000,
    "stockissuedduringperiodsharesother": 5833333,
    "shareissuedduringperiodshareswarrantsexercised": 86143,
    "sharebasedcompensation": 1800000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 18000,
    "increasedecreaseindeferredfinancecosts": -61000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -2760000,
    "increasedecreaseinduetorelatedparties": -473000,
    "increasedecreaseinroyaltiespayable": 1000000,
    "netcashprovidedbyusedinoperatingactivities": -26259000,
    "paymentstoacquireinvestments": 5000000,
    "paymentsforproceedsfromshortterminvestments": -5000000,
    "proceedsfromissuanceofcommonstock": 35000000,
    "paymentsofstockissuancecosts": 2667000,
    "netcashprovidedbyusedinfinancingactivities": 32333000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 6074000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 8745000,
    "priorperiodfinancingcosts1": 833000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1045162,
    "accountspayablecurrent": 354000,
    "accruedemployeebenefitscurrent": 477000,
    "otheraccruedliabilitiescurrent": 270000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 16454,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 261173,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 320654,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 5.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 3.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 20000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 6.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P0Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedinperiod": -86143,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageexerciseprice": 0.6079,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedweightedaverageexerciseprice": 0.0001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 148000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 1100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvesteduponperformance": 311173,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 2000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardplanmodificationdescriptionandterms": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 405849,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 1200000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.14,
    "effectiveincometaxratereconciliationchangeinenactedstatetaxratepercent": 0.01,
    "effectiveincometaxratereconciliationotheradjustments": 0.04,
    "effectiveincometaxratereconciliationtaxcredits": 0.05,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.45,
    "deferredtaxassetsoperatinglosscarryforwards": 19953000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 843000,
    "deferredtaxassetsgoodwillandintangibleassets": 1413000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 15000,
    "deferredtaxassetstaxcreditcarryforwards": 2640000,
    "deferredtaxassetsgross": 24864000,
    "deferredtaxassetsvaluationallowance": 24864000,
    "operatinglosscarryforwards": 111900000,
    "operatinglosscarryforwardexpireperiod": 2035,
    "taxcreditcarryforwardamount": 2600000
  }
]